logo-loader
Callitas Health Inc.

Former Callitas Health CEO Gary Thompson passes away after battle with cancer

James Thompson took over the reins of the Cincinnati-based health and wellness company from his uncle earlier this year

Gary Thompson
Former Callitas Health CEO Gary Thompson was very well regarded in the pharmaceutical industry

Cincinnati-based health and wellness company Callitas Health Inc (CSE:LILY, OTCQB:MPHMF, OTCMKTS: MPHMF) announced Friday that former CEO Gary A Thompson died after a long battle with cancer.

Thompson, who died Tuesday, was a pharmaceutical industry veteran with a career spanning over three decades. He worked with pharmaceutical giants and startups. He served as vice president of sales for Cigna Healthcare (NYSE:CI) before taking over the reins of M Pharmaceutical Inc and later Callitas Health. Thompson was a graduate of Northern Kentucky University, with a BS in Kinesiology.

Callitas Health CEO James Thompson, took over the mantle from his uncle, Gary, earlier this year.

“Gary was a larger-than-life figure who brought his remarkable passion, experience and energy to Callitas Health and he will be greatly missed,” said Callitas Board member William Rodgers.

Callitas Health, which is now spearheaded by the second generation of Thompsons, is a well-diversified company. It has a nimble strategy focused on getting quick revenues from mass-appeal over-the-counter products and a more long-term blockbuster pipeline. It is active across five silos: OTC sexual health & wellness, prescriptions for female sexual health, weight management, cannabis delivery technologies and orphan drugs.

Contact Uttara Choudhury at [email protected]

Follow her on Twitter@UttaraProactive 

Quick facts: Callitas Health Inc.

Price: $0.11

Market: CSE
Market Cap: $3.62 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Callitas Health Inc. named herein, including the promotion by the Company of Callitas Health Inc. in any Content on the Site, the Company...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Callitas Therapeutics signs LOI with Simply Wholeistic, updates on THC & CBD...

Callitas Therapeutics (CSE:LILY) (OTCQB:MPHMF) Vice President of Sales & Business Development Joshua Maurice tells Proactive Investors the pharma company has signed a letter of intent with Simply Wholeistic to manufacture  its CannaStrip products in the U.S. Maurice added that as...

on 04/25/2019

2 min read